Role of Tetanus Neurotoxin Insensitive Vesicle-Associated Membrane Protein (Ti-Vamp) in Vesicular Transport Mediating Neurite Outgrowth by Martinez-Arca, Sonia et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/2000/05/889/11 $5.00
The Journal of Cell Biology, Volume 149, Number 4, May 15, 2000 889–899
http://www.jcb.org 889
 
Role of Tetanus Neurotoxin Insensitive Vesicle-associated Membrane 
 
Protein (TI-VAMP) in Vesicular Transport Mediating Neurite Outgrowth
 
J
 
Sonia Martinez-Arca,*
 
‡
 
 Philipp Alberts,*
 
‡
 
 Ahmed Zahraoui,
 
‡
 
 Daniel Louvard,
 
‡
 
 and Thierry Galli*
 
‡
 
*Group of Membrane Trafﬁc and Neuronal Plasticity, INSERM U536, and 
 
‡
 
Group of Morphogenesis and Cell Signaling, CNRS 
UMR144, Institut Curie, F-75005 Paris, France
 
Abstract. 
 
How vesicular transport participates in neu-
rite outgrowth is still poorly understood. Neurite out-
growth is not sensitive to tetanus neurotoxin thus does 
not involve synaptobrevin-mediated vesicular transport 
to the plasma membrane of neurons. Tetanus neuro-
toxin-insensitive vesicle-associated membrane protein 
(TI-VAMP) is a vesicle-SNARE (soluble 
 
N
 
-ethylmale-
imide-sensitive fusion protein [NSF] attachment pro-
tein [SNAP] receptor), involved in transport to the
apical plasma membrane in epithelial cells, a tetanus 
neurotoxin-resistant pathway. Here we show that
TI-VAMP is essential for vesicular transport-mediating 
neurite outgrowth in staurosporine-differentiated PC12 
 
cells. The NH
 
2
 
-terminal domain, which precedes the 
SNARE motif of TI-VAMP, inhibits the association of 
TI-VAMP with synaptosome-associated protein of 25 
kD (SNAP25). Expression of this domain inhibits neu-
rite outgrowth as potently as Botulinum neurotoxin E, 
which cleaves SNAP25. In contrast, expression of the 
NH
 
2
 
-terminal deletion mutant of TI-VAMP increases 
SNARE complex formation and strongly stimulates 
neurite outgrowth. These results provide the ﬁrst func-
tional evidence for the role of TI-VAMP in neurite out-
growth and point to its NH
 
2
 
-terminal domain as a key 
regulator in this process.
Key words: membrane trafﬁc • neurite outgrowth • 
SNAREs • TI-VAMP • SNAP25
 
Introduction
 
Elongation of axon and dendrites, so-called neurite out-
growth, is a crucial event in neuronal differentiation and
maturation during development of the nervous system
(Prochiantz, 1995). Neurite outgrowth relies primarily on
the transport and addition of new components to the
plasma membrane but little is known about the vesicle tar-
geting and fusion machinery involved in this process (Fu-
terman and Banker, 1996; Bradke and Dotti, 1997).
Membrane traffic can be envisioned as a succession of
vesicle budding, maturation, vectorial transport, tethering,
docking, and lipid bilayer fusion events. Vesicular trans-
port to and fusion at the plasma membrane, i.e., exocyto-
sis, is responsible for the release of soluble compounds,
such as neurotransmitters in the extracellular medium, and
for surface expression of plasma membrane proteins and
lipids. Overwhelming evidence accumulated over the last
years shows that soluble 
 
N
 
-ethylmaleimide–sensitive fu-
sion protein (NSF)
 
1
 
 attachment protein (SNAP) receptors
(SNAREs) are key proteins of membrane traffic, most
likely involved in lipid bilayer fusion (Weber et al., 1998;
Nickel et al., 1999; Parlati et al., 1999; Bock and Scheller,
1999). Clostridial neurotoxins (NTs) carry a proteolytic ac-
tivity, which selectively cleaves defined SNAREs. Hence
they have been extensively used to demonstrate the in-
volvement of NT-sensitive SNAREs in vesicular transport
(for review, see Johannes and Galli, 1998).
Surprisingly, several exocytotic pathways are resistant to
NTs, particularly to tetanus neurotoxin (TeNT), which
cleaves several members of the synaptobrevin (also called
vesicle-associated membrane protein, VAMP) family of
SNAREs. TeNT resistance of the transport to the apical
plasma membrane, in epithelial cells, was originally inter-
preted as the occurrence of SNARE-independent exocyto-
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sis (Ikonen et al., 1995; Simons and Ikonen, 1997). A break-
through resulted from the cloning of synaptobrevin-like
gene 1 (D’Esposito et al., 1996) and the finding that its
product is insensitive to TeNT and Botulinum NTs
(BoNTs) B, D, F, and G (Galli et al., 1998). This protein,
called TeNT-insensitive VAMP (TI-VAMP) or VAMP7,
forms apical SNARE complexes and mediates fusion of
vesicles with the apical plasma membrane (Galli et al.,
1998; Lafont et al., 1999). It is also present in the deg-
radation pathway of EGF in fibroblasts (Advani et al.,
1999). TI-VAMP is a likely candidate for vesicle SNARE
(v-SNARE) of NT-resistant exocytotic pathways. Interest-
ingly, neurite outgrowth is resistant to TeNT, thus does not
involve synaptobrevin and synaptic vesicles (SVs; Osen-
Sand et al., 1996; AhnertHilger et al., 1996). Genetic evi-
dences confirm this. First, in fly and nematode, elimination
of the neuronal synaptobrevin leads to severe impairment of
neurotransmitter release but has no effect on neurite out-
growth (Deitcher et al., 1998; Nonet et al., 1998). Second,
neurite outgrowth is normal in a PC12 clone lacking synap-
tobrevins 1 and 2 (Leoni et al., 1999). In a previous study, we
have shown that TI-VAMP–containing vesicular compart-
ment excludes synaptobrevin 2 and other markers of well-
characterized exocytic and endocytic compartments and it
concentrates in the leading edge of axonal and dendritic pro-
cesses in hippocampal neurons in primary culture (Coco et
al., 1999). In this paper, we show that TI-VAMP fulfills the
criteria to be the v-SNARE implicated in neurite outgrowth.
 
Materials and Methods
 
Antibodies and Clones
 
Rabbit serums (TG11 and TG16; Galli et al., 1998; Lafont et al., 1999) di-
rected against TI-VAMP were purified by affinity chromatography in a
column loaded with a GST fusion protein of the coiled-coil domain of TI-
VAMP (see below). Mouse monoclonal antibodies directed against syn-
aptobrevin 2 (clone 69.1, generous gift from R. Jahn, Max Planck Insti-
tute, Goettingen, FRG), SNAP25 (clone 20, Transduction Labs.), green
fluorescent protein (GFP; clone 7.1 and 13.1, Boehringer), syntaxin 6
(clone 30, Transduction Labs), syntaxin 1 (HPC-1, generous gift from C.
Barnstable, Yale University, New Haven, CT), glutathione-
 
S
 
-transferase
(GST; generous gift from J.-L. Theillaud, Institut Curie, Paris, France),
TeNT light chain (TeNT-LC; generous gift from H. Niemann, Hannover
Medical School, Hannover, Germany), rabbit polyclonal antibodies
against the ectoplasmic domain of synaptotagmin I (8907, generous gift
from P. DeCamilli, Yale University, New Haven, CT), SNAP25 (MC9,
generous gift from P. DeCamilli, Yale University, New Haven, CT), GFP
(Boehringer), and histidine (Santa Cruz Biotechnology, Inc.) have been
described previously. Affinity-purified Cy2 and Texas red–coupled goat
anti–mouse and anti–rabbit immunoglobulins were purchased from Jack-
son Laboratory. Rhodamine-coupled phalloidin was from Sigma-Aldrich.
Alkaline phosphatase-coupled sheep anti–mouse were from Promega.
The cDNAs of human TI-VAMP and cellubrevin were previously de-
scribed (Galli et al., 1998). The cDNAs of rat synaptobrevin 2 (R.
Scheller, Stanford University, Stanford, CA), rat SNAP25A (R. Jahn,
Max Planck Institute, Goettingen, Germany), TeNT-LC and BoNT-LC
(H. Niemann, Hannover Medical School, Hannover, Germany) and ratio-
metric pHLuorin (G. Miesenbock, Sloan Kettering Memorial Hospital,
New York, NY) were generous gifts.
 
Cell Culture
 
PC12 cells were cultured in RPMI supplemented with 10% horse serum
(HS) and 5% FCS as described (Greene and Tischler, 1976). Cells were
plated either on collagen-coated plastic dishes or on poly-
 
L
 
-lysine plus col-
lagen-coated glass coverslips (Chilcote et al., 1995). HeLa cells were cul-
tured in DME supplemented with 10% FCS.
 
DNA constructions: for production of NH
 
2
 
-terminal GFP fusion pro-
teins, the distinct cDNAs were cloned into the pEGFP-C3 vector (CLON-
TECH Laboratories, Inc.). The same empty vector was also used as a con-
trol in some of the neurite outgrowth assays. Full-length TI-VAMP
(TIVAMP), NH
 
2
 
-terminal domain-TIVAMP (Nter-TIVAMP, from M
 
1
 
 to
N
 
120
 
), cytosolic domain-TIVAMP (Cyt-TIVAMP, from M
 
1
 
 to K
 
188
 
),
 
D
 
NH
 
2
 
-terminal domain-TIVAMP (
 
D
 
Nter-TIVAMP, from M
 
102
 
 to the
end), and full-length synaptobrevin 2 (Sb2), were obtained by PCR using
standard procedures and the following sets of oligonucleotides: 5
 
9
 
-ATG-
GCGATTCTTTTTGCTGTTGTTGCC-3
 
9
 
 and 5
 
9
 
-CTATTTCTTCACA-
CAGCTTGGCCATGT-3
 
9
 
 for TIVAMP; 5
 
9
 
-ATGGCGATTCTTTTTG-
CTGTTGTTGCC-3
 
9
 
 and 5
 
9
 
-CTTATTCTCAGAGTGATGCTTCAG-
CTG-3
 
9
 
 for Nter-TIVAMP; 5
 
9
 
-ATGGCGATTCTTTTTGCTGTTGT-
TGCC-3
 
9
 
 and 5
 
9
 
-ATCCTACTTGAGGTTCTTCATACACATGGCTC
for Cyt-TIVAMP; 5
 
9
 
-ATGAATAGCGAGTTCTCAAGTGTCTTA-
3
 
9
 
 and 5
 
9
 
-CTATTTCTTCACACAGCTTGGCCATGT-3
 
9
 
 for 
 
D
 
Nter-
TIVAMP; 5
 
9
 
-ATGTCGGCTACCGCTGCCACCGTCCCG-3
 
9
 
 and 5
 
9
 
-
TTAAGAGCTGAAGTAAACTATGATGAT for Sb2. TIVAMP, Nter-
TIVAMP, Cyt-TIVAMP, and Sb2 were cloned in pEGFP-C3 using the
KpnI-XbaI sites, while 
 
D
 
Nter-TIVAMP was cloned in HindIII-XbaI sites.
For production of the COOH-terminal GFP (ratiometic pHLuorin in
this case) fusion protein of TI-VAMP, TI-VAMP cDNA bearing a BamHI
site in its 3
 
9
 
 was obtained by PCR using the 5
 
9
 
-GGATCCTTTCTTCACA-
CAGCTTGGCCA-3
 
9
 
 and 5
 
9
 
-CTATTTCTTCACACAGCTTGGCCA-
TGT-3
 
9
 
 oligonucleotides, and cloned in the pCR3.1-Uni vector (CLON-
TECH Laboratories, Inc.). Ratiometric pHLuorin was then cloned in the
BamHI-EcoRI sites. Nter-TIVAMP, Cyt-TIVAMP, and coiled-coiled do-
main of TIVAMP (CC-TIVAMP; from E
 
119
 
 to K
 
188
 
) were fused to GST
gene by cloning in pGEX4T vector (Amersham Pharmacia Biotech).
 
Overlay Assay
 
The corresponding GST fusion proteins and GST alone were produced
and purified as described (Galli et al., 1998). 6
 
3
 
his-tagged SNAP25A
(6
 
3
 
hisSNAP25, bacterial strain was a generous gift from G. Schiavo,
ICRF, London, UK) was purified as described (Weber et al., 1998).
6
 
3
 
hisSNAP25 was run on SDS-PAGE and Western blotted onto Immo-
bilon-P membrane (Millipore). The amount of 6xhisSNAP25 corresponds
to 1.25 
 
m
 
g/mm of membrane. 4-mm strips of the membrane were cut and
incubated in 150 mM NaCl, 5% nonfat dry milk, 50 mM phosphate, pH
7.5, for buffer for 1 h at room temperature. The strips were then incubated
with 10 nM of the GST fusion proteins overnight at 4
 
8
 
C in buffer B (3%
BSA, 0.1% Tween 20, 20 mM Tris, pH 7.5) containing 1 mM DTT. The
strips were rinsed three times in buffer B at room temperature, incubated
with anti-GST antibodies in buffer B for 1 h, rinsed in buffer B three times
and incubated with alkaline phosphatase-coupled sheep anti–mouse anti-
bodies. The detection was carried out simultaneously for all the strips, for
the same time, using a kit from Promega.
 
Cell Transfection
 
PC12 or HeLa cells were trypsinized, washed, and resuspended at a den-
sity of 7.5–10 
 
3
 
 10
 
6
 
 cells/ml in Optimix (Equibio). Electroporation was
performed with 10 
 
m
 
g DNA in a final volume of 0.8 ml cell suspension us-
ing a Gene Pulser II device (Bio-Rad) with one shock at 950 
 
m
 
F and
250 V. When GFP was cotransfected with TeNT or BoNTE for monitor-
ing the transfected cells, the plasmid carrying the GFP gene was added at
double concentration in order to ensure that all the cells that uptake it
also uptake the plasmid carrying the toxin. Immediately after electropora-
tion, cells were washed with 5 ml of complete medium before plating them
for immunoprecipitation or immunofluorescence microscopy analysis. 5 h
later, the outgrowth medium was removed and replaced with fresh me-
dium containing 100 nM staurosporine (Sigma-Aldrich). PC12 and HeLa
cells were processed 24 or 48 h after transfection, respectively. For en-
hanced expression of the exogenous proteins, 5 mM sodium butyrate was
added in all the cases during the last 6 h before processing the cells.
 
Antibody Uptake Assay
 
PC12 cells processed as indicated above were incubated in the presence of
5 
 
m
 
g/ml anti-GFP antibody in culture medium for 15 min on ice, 15 min on
ice then 15 min at 37
 
8
 
C, or 15 min on ice then 60 min at 37
 
8
 
C, 24 h after
transfection with GFP-TIVAMP or TIVAMP-GFP. The cells were then
washed twice with culture medium and twice with PBS, fixed with PFA,
and processed for immunofluorescence. 
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Immunocytochemistry
 
Cells were fixed with 4% PFA and processed for immunofluorescence as
previously described (Coco et al., 1999). Optical conventional microscopy
was performed on a Leica microscope equipped with a MicroMax CCD
camera (Princeton Instruments). Confocal laser scanning microscopy was
performed using a TCS confocal microscope (Leica). Images were assem-
bled without modification using Adobe Photoshop.
 
Neurite Outgrowth Assay
 
Cells were fixed 24 h after transfection. Between 20 and 100 randomly
chosen fields for each condition were taken with a MicroMax CCD cam-
era (Princeton Instruments), resulting in the analysis of at least 50 GFP-
positive cells. A neurite was defined as a thin process longer than 5 
 
m
 
m.
Using the Metamorph software (Princeton Instruments) two parameters
were scored in each case: the number of neurites per cell (from 0 to 4 or
more neurites), and the length of each neurite, from the cell body limit un-
til the tip of the process. The obtained data were analyzed for their statis-
tical significance with SigmaStat (SPSS, Inc.). All the recordings and the
Metamorph analysis were done in blind.
 
Videomicroscopy
 
Living PC12 cells transfected and treated with staurosporine as described
above were placed in complete medium in an appropriate chamber equili-
brated at 37
 
8
 
C and 5% CO
 
2
 
. Cells were monitored with a MicroMax CCD
camera (Princeton Instruments) for as much as 9 h, taking images both
through phase contrast and FITC fluorescence every 2 min or every 15 s.
Images were assembled using Metamorph (Princeton Instruments).
 
Immunoprecipitation
 
Immunoprecipitation from rat brain was performed using a Triton X-100–
soluble membrane fraction prepared as follows: two adult rat brains were
homogenized with a glass/teflon homogenizer (9 strokes at 900 rpm) in 25
ml of 0.32 M sucrose containing a protease inhibitor cocktail. All the steps
were carried out at 4
 
8
 
C. After 10 min centrifugation at 800 
 
g
 
 the superna-
tant was centrifuged at 184,000 
 
g
 
 for 1 h, obtaining a cytosolic and a mem-
brane fraction in the supernatant and the pellet, respectively. The pellet
was resuspended in TSE (50 mM Tris, pH 8.0, 0.5 mM EDTA, and 150
mM NaCl) containing 1% Triton X-100 for 30 min and finally the insolu-
ble material was removed by centrifugation at 184,000 
 
g
 
 for 1 h. Immuno-
precipitation with anti-SNAP25 antibodies and mouse control IgGs was
performed from 2 mg of proteins from the soluble extract. Immunoprecip-
itations from transfected PC12 or HeLa cells were performed using a total
Triton X-100–soluble fraction prepared as follows: after two washes with
cold TSE, cells were lysed for 1 h under continuous shaking with TSE con-
taining 1% Triton X-100 and protease inhibitors. The supernatant result-
ing from centrifugation at 20,000 
 
g
 
 for 30 min was used for immunoprecip-
itation. After overnight incubation of the brain and cell extracts with the
antibodies, 50 
 
m
 
l of magnetic beads (Dynabeads; Dynal) were added for
2–4 h. The magnetic beads were washed four times with TSE containing
1% Triton X-100, eluted with gel sample buffer and the eluates were
boiled for 5 min and run on SDS-PAGE gels (Schagger and von Jagow,
1987).
 
Online Supplemental Material
 
To better visualize GFP-TIVAMP dynamics in staurosporine-differenti-
ated PC12 cells, we advise the reader to consult the supplementary video
available online at http://www.jcb.org/cgi/content/full/149/4/889/DC1. This
video corresponds to the same GFP-TIVAMP–expressing cell as pre-
sented in Fig. 2, shown here during a longer period of time (6 h), with im-
ages taken every 2 min (8 images/s). The movie shows the dynamics of
GFP-TIVAMP (bottom) in the course of neurite outgrowth (as seen
by transmission light [TL], top). Note that most movements of GFP-
TIVAMP–containing vesicles are anterograde.
 
Results
 
TI-VAMP Dynamics in Staurosporine-treated
PC12 Cells
 
Differentiation of neurons and nerve growth factor (NGF)-
induced neurite outgrowth of PC12 cells take several days
(Luckenbill-Edds et al., 1979). On the contrary, staurospo-
rine, a protein kinase inhibitor, induces maximal neurite
outgrowth in 24 h of treatment in PC12 cells (Yao et al.,
1997). Our neurite outgrowth assay is based on treating
PC12 cells with 100 nM staurosporine for 24 h. These ex-
perimental conditions do not induce apoptosis in PC12
cells (Yao et al., 1997; Li et al., 1999). Fig. 1 shows that
synaptobrevin 2, TI-VAMP, SNAP25, and synaptotagmin
I had a normal subcellular localization in staurosporine-
treated PC12 cells (Fig. 1). Synaptobrevin 2 concentrated
in the perinuclear region and in neuritic tips. TI-VAMP–
positive vesicles were scattered throughout the cytoplasm
and concentrated at the leading edge of extending neu-
rites. Synaptotagmin I appeared almost exclusively in neu-
rites and varicosities and SNAP25 was present throughout
the plasma membrane. This pattern of immunostaining
was similar to that observed in NGF-treated PC12 cells
(Chilcote et al., 1995; Coco et al., 1999), demonstrating the
validity of this cellular model to study neurite outgrowth.
We produced TI-VAMP carrying a GFP tag fused to the
NH
 
2
 
-terminal end (GFP-TIVAMP, see Fig. 4 B). Upon
transfection of this construct in PC12 cells, GFP staining
was indistinguishable from that of endogenous TI-VAMP
by confocal microscopy (data not shown), thus discarding
the possibility that fusion of the GFP tag could alter TI-
VAMP trafficking. We then observed TI-VAMP dynamics
by time-lapsed videomicroscopy in staurosporine-treated
Figure 1. Localization of membrane markers in horizontal confo-
cal sections of staurosporine-differentiated PC12cells. PC12 cells
were treated with 100 nM staurosporine for 24 h, fixed and pro-
cessed for immunofluorescence with anti-synaptobrevin 2 (Sb2)
and anti–TI-VAMP (TIVAMP), anti-SNAP25 (SNAP25) or anti-
synaptotagmin I (Syt I) antibodies. The cells were then observed
by confocal microscopy. Note the lack of colocalization of synap-
tobrevin 2 and TI-VAMP, the restricted localization of SNAP25
at the plasma membrane and the concentration of synaptotagmin
I at the tip of neurites. Bar, 5 mm. 
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PC12 cells, which had been previously transfected with
GFP-TIVAMP (Fig. 2). Fast growing neurites were re-
corded every 2 min over periods of 3–9 h, 5 h after the on-
set of staurosporine treatment. Fig. 2 A displays transmis-
sion and fluorescent light images recorded every 24 min
during 2 h 2 min (see also accompanying movie). High
magnification view of a neurite growing towards the bot-
tom right of the image is shown in the inset. At each time
point, GFP-TIVAMP–containing vesicles distributed along
this growing process, up to the leading edge of the growth
cone (Fig. 2 A). Most movements of GFP-TIVAMP–con-
taining membranes were anterograde (Fig. 2 B).
We then constructed another form of fluorescent
TI-VAMP by introducing a GFP tag at the COOH termi-
nus (TIVAMP-GFP, see Fig. 4 B). In this case, the GFP
tag is exposed to the extracellular medium after exocytosis
of TI-VAMP–containing vesicles. TIVAMP-GFP–trans-
fected PC12 cells were labeled with monoclonal antibodies
directed against GFP while they were placed on ice, before
fixation. The labeling was often concentrated at the tip of
the growing neurite (Fig. 3). When the cells were allowed
to internalize the antibody at 37
 
8
 
C, we observed a fast,
time-dependent uptake. After 15 min at 37
 
8
 
C, the anti-
GFP immunoreactivity was seen in peripheral structures,
 
very close to the plasma membrane with a low degree of
overlap with the green signal emitted by the bulk of
TIVAMP-GFP. After 60 min, most of the immunoreac-
tivity colocalized with TIVAMP-GFP, indicating that
the anti-GFP antibody had reached the entire TIVAMP-
GFP compartment. We did not detect any plasma mem-
brane labeling nor GFP antibody internalization in GFP-
TIVAMP–transfected or untransfected cells (Fig. 3) thus
demonstrating the lack of capture of the antibody by fluid
phase uptake. Altogether, these studies demonstrate that
the dynamics of TI-VAMP–containing vesicles very closely
accompany the growth of neurites and that the protein re-
cycles at the neuritic plasma membrane.
 
The NH
 
2
 
-terminal Domain of TI-VAMP Inhibits 
SNARE Complex Formation
 
Because TI-VAMP is resistant to NT treatment, new ex-
perimental approaches had to be developed to study its
function in living cells. Towards this goal, we searched
for mutated forms of TI-VAMP that would have impaired
SNARE complex formation activity. We first identified
SNAP25 as a main physiological target SNARE (t-SNARE)
of TI-VAMP. SNAP25, a neuronal plasma membrane
Figure 2. Dynamics of GFP-TIVAMP-vesicles. PC12 cells transfected with GFP-TIVAMP were treated with staurosporine for 5 h and
observed under time-lapsed videomicroscopy in the presence of staurosporine. (A) GFP-TIVAMP vesicles accompany the growth of
neurites. Transmission and fluorescent light images were recorded every 2 min over a period of 8 h. Images recorded every 24 min
through the middle period of the whole recording are shown (see also movie). The inset shows a higher magnification of a growing neu-
rite. Arrows indicate regions of this neurite where GFP-TIVAMP concentrates. (B) GFP-TIVAMP vesicles dynamics in neurites. Fluo-
rescent light images were recorded every 15 s over a period of 30 min (bottom right number, time in s). Images recorded during a 1-min
period of the recording are shown. The arrow indicates a GFP-TIVAMP vesicle which is moving anterogradely. See supplemental video
at http://www.jcb.org/cgi/content/full/149/4/889/DC1. Bars: (A) 5 mm; (B) 1 mm. 
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Q-SNARE, formed abundant SNARE complexes with TI-
VAMP as seen by coimmunoprecipitation experiments
performed from brain extracts. Cellubrevin, a v-SNARE
that is expressed in glial cells but not in neurons (Chilcote
et al., 1995), did not associate with SNAP25 thus showing
that the SNARE complexes were not formed during solu-
bilization of brain membranes (Fig. 4 A).
Protein sequence analysis of TI-VAMP shows that the
protein has an original NH
 
2
 
-terminal (Nter) domain of 120
amino acids, located upstream of the coiled-coiled domain
(also called R-SNARE motif; Galli et al., 1998; Jahn and
Sudhof, 1999). This Nter domain includes three regions
predicted to be 
 
a
 
 helical by Hydrophobic Cluster Analysis
(Callebaut et al., 1997) and Jpred (Cuff et al., 1998; data
not shown). This is reminiscent of the Nter domain of syn-
taxin 1, which comprises 3 
 
a
 
 helices (Fernandez et al.,
1998) and inhibits lipid bilayer fusion (Parlati et al., 1999).
The Nter domain of Sso1p, the yeast homologue of syn-
taxin 1, inhibits the rate of SNARE complex formation
(Nicholson et al., 1998). Similar Nter domains are present
in the other plasma membrane but not in intracellular syn-
taxins (Fernandez et al., 1998), indicating that this function
may be specific for exocytosis. This led us to prepare the
following GST fusion proteins: full cytoplasmic domain
of TI-VAMP (GST-Cyt-TIVAMP), coiled-coiled domain
alone (GST-CC-TIVAMP), and Nter domain alone (GST-
Figure 3. TI-VAMP recycles
at the neuritic plasma mem-
brane. PC12 cells transfected
with TIVAMP-GFP or GFP-
TIVAMP and treated with
staurosporine for 20 h were
placed on ice, incubated with
monoclonal antibody anti-
GFP (5 mg/ml) for 15 min,
and directly fixed (159/48C)
or further incubated at 378C
for 15 min (1159/378C) or 60
min (1609/378C) before fixa-
tion. Note the dense labeling
of the neuritic plasma mem-
brane in the 159/48C and
1159/378C conditions. Full
loading of the GFP-TIVAMP
compartment is reached in
the  1609/378C condition. Bar,
5 mm. 
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Nter-TIVAMP; Fig. 4 B), and to measure the binding of
the corresponding proteins to immobilized 6xhis-SNAP25
in an overlay assay. GST-CC-TIVAMP bound very ef-
ficiently immobilized his-SNAP25 whereas GST-Cyt-
TIVAMP bound very poorly. As controls, GST alone
and GST-Nter-TIVAMP did not bind immobilized his-
SNAP25 (Fig. 4 C). To perform in vivo experiments,
we constructed the following GFP-tagged forms of TI-
VAMP: TI-VAMP deleted of its Nter domain (GFP-
 
D
 
Nter-TIVAMP) and Nter domain alone (GFP-Nter-
TIVAMP; Fig. 4 B). HeLa cells do not express endoge-
nous SNAP25, so we used them to study the association
of SNAP25 with GFP-TIVAMP, GFP-
 
D
 
Nter-TIVAMP,
GFP-Nter-TIVAMP (Fig. 4 B), or GFP, in vivo, after
cotransfection. We measured the amount of GFP-tagged
proteins coimmunoprecipitating with SNAP25 from Tri-
ton X-100–soluble extracts. GFP-
 
D
 
Nter-TIVAMP formed
more abundant SNAP25-containing SNARE complexes
than GFP-TIVAMP. As controls, GFP and GFP-Nter-
TIVAMP did not bind SNAP25 (Fig. 4 D). Altogether, we
propose that the Nter domain exerts an intramolecular in-
hibition of the SNARE complex formation activity of TI-
VAMP’s coiled-coiled domain.
 
TI-VAMP Mediates Neurite Outgrowth
 
An assay was set up to measure the effect of transfection
of NTs and TI-VAMP mutants on staurosporine-induced
Figure 4. Biochemical properties of
the TI-VAMP–SNAP25 complex. (A)
TI-VAMP forms a complex with
SNAP25 in Triton X-100 extract of rat
brain. Immunoprecipitation with anti-
SNAP25 antibodies was performed
from Triton X-100–soluble extract of
rat brain as described in Materials and
Methods and immunoprecipitated pro-
teins were detected by Western blot
analysis with the indicated antibodies
(Sb2, synaptobrevin 2; Cb, cellubrevin;
U, unbound; B, bound to anti-SNAP25
immunobeads). The bound fraction
corresponded to a 65-fold enrichment
compared with unbound. The
SNAP25–TI-VAMP complex seemed
more abundant than the SNAP25–syn-
aptobrevin 2 complex but this may
only reflect a lower expression level of
TI-VAMP compared with synapto-
brevin 2 in the adult brain. Note that
cellubrevin did not coimmunoprecip-
itate with SNAP25. (B) Structure of
TI-VAMP and TIVAMP–derived con-
structs. TI-VAMP is composed of
three domains: the Nter domain
(amino acids 1–120), the coiled-coiled
domain, also called R-SNARE motif
(CC, amino acids 121–180), and one
comprising the transmembrane do-
main and a short luminal domain (TM,
amino acids 181 to 220). These do-
mains were tagged with GFP and GST
as depicted. (C) The Nter domain of
TI-VAMP inhibits binding of TI-
VAMP to SNAP25. The binding of
GST, GST-Cyt-TIVAMP, GST-Nter-
TIVAMP, or GST-CC-TIVAMP was
measured by overlay over immobilized
63his-SNAP25 (indicated by the ar-
row). GST-CC-TIVAMP bound effi-
ciently to immobilized 63his-SNAP25.
Little binding of GST-Cyt-TIVAMP
and none of GST and GST-Nter-TIVAMP was observed. As positive control, a strip was revealed with anti-63histidine antibodies. (D)
A TI-VAMP mutant lacking the Nter domain coimmunoprecipitates with SNAP25 more efficiently than full-length TI-VAMP. HeLa
cells cotransfected with SNAP25 plus GFP-DNter-TIVAMP, GFP-TIVAMP, GFP-Nter-TIVAMP, or GFP were lysed and subjected to
immunoprecipitation with mouse monoclonal anti-SNAP25 antibodies as described in Materials and Methods. The immunoprecipitated
proteins were then detected by Western blot with anti-GFP or anti-SNAP25 rabbit polyclonal antibodies. The bound fraction corre-
sponded to a 100-fold enrichment compared with the starting material (SM) in the case of the GFP blot and to a 10-fold enrichment in
the case of the SNAP25 blot. Note that neither GFP-Nter-TIVAMP nor GFP coimmunoprecipitated with SNAP25.Martinez-Arca et al. TI-VAMP and Neurite Outgrowth 895
neurite outgrowth in PC12 cells. First, we showed that
when cells were electroporated with two plasmids, virtu-
ally all cells expressed both transgenes. This was demon-
strated by transfection with GFP-cellubrevin (GFP-Cb)
alone, TeNT alone, or both. Cotransfection of TeNT with
GFP-Cb resulted in total proteolysis of GFP-Cb (not
shown). Second, the activities of transfected TeNT and
BoNT E were demonstrated by complete proteolysis of
endogenous synaptobrevin 2 and SNAP25, respectively
(not shown).
In a first set of experiments, PC12 cells were transfected
with GFP alone, GFP plus TeNT, GFP plus BoNT E or
GFP-Nter-TIVAMP. The cells were then treated with
staurosporine and fixed after 24 h. Fig. 5 A shows a repre-
sentative field observed in each condition. Neurites from
cells transfected with GFP or GFP plus TeNT were simi-
lar to neurites from untransfected cells. Neurites from
cells transfected with GFP plus BoNT E or GFP-Nter-
TIVAMP were fewer and shorter. The length of neurites
and the number of neurites per cell were measured in each
GFP-positive cell, in each condition. GFP plus TeNT had
no effect on neurite number and length compared with
GFP alone. BoNT E reduced by 45% the number of neu-
rites longer than 20 mm and strongly increased the number
of cells without neurites (Fig. 5, B and C). Expression of
the Nter domain of TI-VAMP had an effect that was simi-
lar to that of BoNT E. GFP-Nter-TIVAMP reduced by
42% the number of neurites longer than 20 mm and
strongly increased the number of cells without neurites
(Fig. 5, B and C). The effects of GFP plus BoNT E and
GFP-Nter-TIVAMP were statistically different from GFP
alone with P 5 0.027 and 0.017 (Student’s t test), respec-
tively. The effects of BoNT E and GFP-Nter-TIVAMP
were not additive (not shown), indicating that they act on
the same exocytotic mechanism. In a different set of ex-
periments, we measured the effect of GFP and the cy-
toplasmic domain (Nter and coiled-coiled domains) of
TI-VAMP fused to GFP (GFP-Cyt-TIVAMP, Fig. 4 B).
GFP-Cyt-TIVAMP (neurites longer than 20 mm: 50.2% 6
0.25) had no effect on neurite length compared with GFP
(neurites longer than 20 mm: 50.7% 6 3.5). GFP-Cyt-
TIVAMP had no effect on the number of neurites per cell
(not shown). These results demonstrated that neurite out-
growth in staurosporine-treated cells is insensitive to
TeNT but sensitive to BoNT E as in neurons. The fact
that GFP-Nter-TIVAMP inhibited neurite outgrowth as
strongly as BoNT E suggests that TI-VAMP plays a major
role in neurite outgrowth.
We then checked that GFP-Nter-TIVAMP expression
did not have a deleterious effect. Fig. 6 shows a gallery of
double immunofluorescence experiments performed in
GFP-Nter-TIVAMP–transfected cells. We observed no ef-
Figure 5. Expression of the Nter domain of TIVAMP inhibits
neurite outgrowth. (A) Effect of GFP, GFP plus TeNT, GFP plus
BoNT E, or GFP-Nter-TIVAMP on neurite outgrowth. PC12
cells transfected with the indicated constructions and treated
with staurosporine were fixed and direct fluorescence images
were recorded. Representative fields of the distinct phenotypes
found are shown. Note the long neurites displayed both by the
GFP and the GFP1TeNT–transfected cells compared with the
shorter ones displayed by the GFP1BoNT E and the GFP-
Nter-TIVAMP-transfected cells (arrowheads). (B) GFP-Nter-
TIVAMP and BoNT E inhibit neurite length. Percentage of neu-
rites longer than 20 mm. A minimum of 50 transfected cells of
each type was recorded in blind, and the length of all their neu-
rites was measured. The mean values (6SE) of percentage of
neurites longer than 20 mm from three independent experiments
are shown. *P , 0.03 (Student’s t test). Note the lack of effect of
TeNT and that BoNT E and GFP-Nter-TIVAMP had a similar
inhibitory effect on neurite length. (C) Number of neurites per
cell. The same randomly chosen transfected cells were use to
quantify the number of neurites per cell. Shown is the number of
cells, expressed as the percentage of transfected cells, displaying
1, 2, 3, or . 4 neurites. The mean values (6SE) of three indepen-
dent experiments are shown. Note the lack of effect of TeNT and
that both BoNT E and GFP-Nter-TIVAMP enhanced the per-
centage of cells without neurites. Bar, 25 mm.The Journal of Cell Biology, Volume 149, 2000 896
fect on the localization of syntaxin 1, a plasma membrane
SNARE, syntaxin 6, a Golgi apparatus SNARE (Fig. 6),
and SNAP25 (not shown) when compared with untrans-
fected or GFP-transfected cells. Synaptobrevin 2 appeared
both in the perinuclear region and in the shorter neurites
emerging from GFP-Nter-TIVAMP cells (Fig. 6 and com-
pare with Fig. 1). These cells showed a lower level of ex-
pression of synaptotagmin I. Synaptotagmin I was the ve-
sicular marker which was the most enriched in the tip of
the neurites in untransfected cells (Figs. 1 and 6) so our re-
sult may suggest that synaptotagmin I reached the neuritic
tip by a TI-VAMP–dependent pathway. These results
showed that the Nter domain of TI-VAMP had a specific
inhibitory effect on neurite outgrowth.
We then tested the effect of GFP-DNter-TIVAMP ex-
pression and compared it with that of GFP-TIVAMP on
neurite outgrowth. We observed the occurrence of unusu-
ally long neurites with an increased number of filopodia.
Staining of actin filaments with fluorescent phalloidin
showed that the neurites of GFP-DNter-TIVAMP–trans-
fected cells showed cortical actin localization similar to
GFP-TIVAMP–transfected cells (Fig. 7 A). The pattern of
staining of tubulin, synaptobrevin 2, synaptotagmin I,
SNAP25, and syntaxin 1 was the same in GFP-DNter-
TIVAMP as in GFP-TIVAMP–transfected and in
untransfected cells (data not shown). The effect of GFP-
DNter-TIVAMP was quantified as in the case of GFP-
Nter-TIVAMP. GFP-DNter-TIVAMP expression doubled
the number of neurites longer than 30 mm and multiplied by
5 the number of neurites longer than 50 mm when compared
with the expression of GFP-TIVAMP (Fig. 7 B). GFP-
TIVAMP had no effect on neurite length and number per
cell compared with GFP alone (not shown). We observed
no effect of GFP-DNter-TIVAMP on the number of neu-
rites per cell (not shown). We checked that GFP-DNter-
TIVAMP formed more abundant SNARE complexes
with endogenous SNAP25 by measuring the amount of
SNAP25 and syntaxin 1 that was coimmunoprecipitated
with GFP-DNter-TIVAMP, GFP-TIVAMP, and GFP-
Sb2. GFP-DNter-TIVAMP–SNAP25 complex was 2.5
times more abundant than GFP-TIVAMP–SNAP25. Ac-
cordingly, GFP-DNter-TIVAMP coimmunoprecipitated
more syntaxin 1 than GFP-TIVAMP (Fig. 7 C). These re-
sults showed that a form of TI-VAMP, which had a higher
SNARE complex formation activity, strongly enhanced
neurite outgrowth.
Discussion
This study demonstrates that TI-VAMP–mediated vesicu-
lar transport is essential for neurite outgrowth. Expression
of the NH2-terminal domain of TI-VAMP inhibits neurite
outgrowth as strongly as BoNT E, which abolishes the ex-
pression of SNAP25, a plasma membrane SNARE partner
of TI-VAMP. On the contrary, activation of neurite out-
growth and increased SNARE complex formation were
observed when the NH2 terminus deletion mutant of TI-
VAMP was expressed in PC12 cells.
A main conclusion from our work is that TI-VAMP is
involved in neurite outgrowth in PC12 cells. Our finding
that TI-VAMP interacts with SNAP25 in PC12 cells and in
the brain is consistent with the involvement of SNAP25 in
neurite outgrowth (Osen-Sand et al., 1993, 1996). The TI-
VAMP–dependent vesicular transport mediating neurite
outgrowth in PC12 cells likely corresponds to the out-
growth of axons and dendrites in developing neurons. In-
Figure 6. Morphology of GFP-Nter-TIVAMP–expressing cells.
PC12 cells transfected with GFP-Nter-TIVAMP and treated with
staurosporine as in Fig. 5 were fixed, processed for double fluo-
rescence by combining direct GFP fluorescence detection with
indirect immunofluorescence detection using the indicated anti-
bodies. Representative GFP-Nter-TIVAMP–transfected cells
without or with short neurite(s) are shown in horizontal confocal
sections. Syntaxin (Stx) 1 and 6 and synaptobrevin 2 (Sb2) have a
localization similar in untransfected as in GFP-Nter-TIVAMP–
expressing cells. Synaptotagmin I immunoreactivity was weaker
in GFP-Nter-TIVAMP–transfected cells than in untransfected
cells. Bar, 10 mm.Martinez-Arca et al. TI-VAMP and Neurite Outgrowth 897
deed, TI-VAMP concentrates in the leading edge of ax-
onal and dendritic growth cones of hippocampal neurons
in primary culture (Coco et al., 1999). In support of this
conclusion, preliminary experiments have shown a de-
creased number of neurites in young hippocampal neu-
rons, which were microinjected with anti-TIVAMP anti-
bodies (Coco, S., M. Matteoli, and T. Galli, unpublished
observations). Neurite outgrowth may be also very active
in differentiated neurons because it may participate to
post-synaptic morphological changes related to plasticity
and learning (MaleticSavatic et al., 1999). A role for
SNAP25 in neuronal plasticity and learning has been pro-
posed (Catsicas et al., 1994; Boschert et al., 1996). There-
fore, the TI-VAMP– and SNAP25-dependent vesicular
transport mechanism described here could also mediate
activity-dependent exocytosis involved in dendrite elonga-
tion and post-synaptic receptor expression at the plasma
membrane in mature neurons (MaleticSavatic et al., 1999;
Noel et al., 1999; Shi et al., 1999). This could account for
the distribution of TI-VAMP–containing vesicles through-
out the dendrites (Coco et al., 1999) and of SNAP25 in the
dendritic plasma membrane (Galli et al., 1995; Garcia et
al., 1995) of mature neurons.
In a previous study, we proposed that TI-VAMP defines
a novel tubulovesicular compartment, which excludes SV
and endosomal markers, partially overlaps with CD63 and
could correspond to a constitutive-like secretory compart-
ment in neuronal cells (Coco et al., 1999). Interestingly,
CD63 was recently found in Weibel-Palade bodies, which
secrete von Willebrand factor and transport P-selectin, in
endothelial cells (Kobayashi et al., 2000). In fibroblasts,
TI-VAMP partially overlaps with lysosome-associated
membrane protein 1 (LAMP1) and antibodies against TI-
VAMP inhibit the degradation of EGF (Advani et al.,
1999). These findings together with the present data show-
ing that TI-VAMP mediates neurite outgrowth could be in
favor of the involvement of TI-VAMP in constitutive-like
secretion in neurons, a pathway related to secretory lyso-
somes in non-neuronal cells. Indeed, some of the constitu-
tive secretory proteins are targeted to immature secretory
granules in neuronal cells. Then, they are removed from
maturing granules and sent to immature secretory gran-
ule-derived vesicles, together with lysosomal enzymes.
Immature secretory granule-derived vesicles reach the
plasma membrane and release their content in the extra-
cellular medium thus defining a constitutive-like secretory
pathway in neuronal cells (Thiele et al., 1997). Future
studies should aim to determine which cargo proteins and
Figure 7. Expression of a
TIVAMP mutant lacking the
NH2-terminal domain en-
hances neurite outgrowth.
(A) Morphology of PC12
cells transfected with GFP-
TIVAMP or GFP-DNter-
TIVAMP. The cells were
transfected, treated with
staurosporine as in Fig. 5,
fixed/permeabilized, and pro-
cessed for double fluores-
cence by combining direct
GFP fluorescence detection
with indirect immunofluores-
cence detection using Texas
red–phalloidin to visualize
the actin filaments. Note the
occurrence of numerous
filopodia in the neuritic tip of
the GFP-DNter-TIVAMP–
transfected cell. (B) GFP-
DNter-TIVAMP increases
neurite length. A minimum
of 100 transfected cells of
each type was recorded in
blind, and the length of all
their neurites was measured.
The mean values (6SE) of
the percentage of neurites
longer than 30 or 50 mm from
three independent experi-
ments is shown. *** Indicates P , 0.001 (Student’s t test). (C) GFP-DNter-TIVAMP enhances formation of SNARE complexes. A Tri-
ton X-100–soluble extract was prepared from PC12 cells transfected with GFP-TIVAMP, GFP-DNter-TIVAMP, or GFP-Sb2 and
subjected to overnight immunoprecipitation with monoclonal anti-GFP antibodies. Immunoprecipitated proteins were resolved in
SDS-PAGE followed by Western blot analysis with the indicated antibodies. Note the increased coimmunoprecipitation of endogenous
SNAP25 with GFP-DNter-TIVAMP compared with GFP-TIVAMP. The histogram in the right side shows the quantification of the
amount of endogenous SNAP25 immunoprecipitated normalized to the amount of GFP fusion protein immunoprecipitated from two
independent experiments. **P , 0.01 (Student’s t test). Bar, 10 mm.The Journal of Cell Biology, Volume 149, 2000 898
lipids TI-VAMP–containing vesicles transport in neurons.
According to our working hypothesis, the proteic and li-
pidic map of TI-VAMP vesicular compartment is likely to
identify factors, which are important for neurite elonga-
tion both in developing and mature neurons. The purifica-
tion of TI-VAMP vesicular compartment will also be im-
portant to determine which other proteins are involved in
this pathway, particularly rab proteins that have been
shown to play a role in neurite outgrowth (Ayala et al.,
1990; Huber et al., 1995).
The mechanism of action of the NH2-terminal domain
of TI-VAMP has not been yet fully resolved but it is remi-
niscent of the inhibitory effects of NH2-terminal domains
of Sso1p and syntaxin 1. NH2-terminal deletion mutant of
Sso1p has an increased SNARE complex formation rate.
The NH2-terminal domain of Sso1p binds to its SNARE
motif and inhibits SNARE complex formation in vitro,
thus acting as an intramolecular inhibitor of the SNARE
motif (Nicholson et al., 1998). Removal of the NH2-termi-
nal domain of syntaxin 1 decreases SNARE-dependent li-
posome fusion half time from 40 to 10 min. In this case, no
effect is observed on SNARE complex formation rate
(Parlati et al., 1999). We found that the cytoplasmic do-
main of TI-VAMP, which comprises the NH2-terminal
domain plus the R-SNARE motif, had no effect on neu-
rite outgrowth, whereas the NH2-terminal domain alone
strongly inhibited it. This demonstrates that the full cyto-
plasmic domain is inactive in vivo. The coiled-coiled do-
main of TI-VAMP bound more efficiently SNAP25 than
the cytoplasmic domain by overlay assay. Therefore, our
observations would favor a model in which the NH2-ter-
minal domain of TI-VAMP inhibits the capacity of the
R-SNARE motif to form SNARE complexes and promote
fusion, maybe because the NH2-terminal domain folds
over the R-SNARE motif or by a yet unknown mecha-
nism. Cytosolic or membrane proteins can be expected to
act on the NH2-terminal domain of TI-VAMP to permit
fusion at maximal rate. The inhibitory effect on neurite
outgrowth resulting from expression of the NH2-terminal
domain of TI-VAMP could be due to the sequestration of
such factor(s). Conversely, the activatory effect of the
DNter-TIVAMP could be explained by the fact that it by-
passed control by such factors. Hence, identifying the sig-
nal transduction pathway(s) and factors, able to activate
TI-VAMP, will be of crucial importance to further under-
stand how neurite outgrowth is controlled.
Finally, our finding that the NH2-terminal domain of TI-
VAMP plays an important function in the control of neu-
rite outgrowth, suggests that this protein is a potential
target of pharmacological agents that could modulate
the activity of TI-VAMP by releasing the inhibition of
this domain. Such agents could specifically activate TI-
VAMP–mediated exocytosis thus stimulate neurite out-
growth. Once identified, such drugs could be used in the
treatment of nerve traumatisms such as spinal cord injury.
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